Skip to content

Breast Stimulation Versus Pitocin for Induction of Labor

Breast Pump Nipple Stimulation Versus Pitocin for Induction of Labor: Efficacy, Safety and Satisfaction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00984347
Enrollment
150
Registered
2009-09-25
Start date
2009-11-30
Completion date
2010-12-31
Last updated
2009-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Induction

Keywords

nipple stimulation, Oxytocin, induction of labor, term pregnancies, grandmultipara, VBAC, PROM, comparison of two methods for induction of labor

Brief summary

The purpose of the trial is to compare nipple stimulation with a breast pump to pitocin for induction of labor in term pregnancies.

Interventions

DRUGOxytocin

For low risk group (women at deliveries 1-5): IV oxytocin 10IU/1000ml standard sol. starting at 2MU/MIN and augmenting 2MU every 20 min. For high risk group (grandmultiparas \[6th delivery and up\] or women with a previous cesarean section) IV oxytocin 5IU/1000ml standard sol. starting at 1MU/MIN augmenting 1MU every 20 MIN - in accordance with the department's protocol

PROCEDUREbreast pump nipple stimulation

breast pump calibrated at lowest suction strength, operated alternately: 15 min one breast, 15 min second breast, 15 min rest

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 years and older * completed 37 weeks gestation * singleton pregnancy * reassuring fetal heart rate at admission monitor

Exclusion criteria

* multiple pregnancies * known fetal malformations * non reassuring NST * polyhydramnios (AFI\>220) * oligohydramnios * PET * IUGR * macrosomia (EFW \>4000g) * antepartum bleeding * maternal fever

Design outcomes

Primary

MeasureTime frame
time from induction to delivery24h

Secondary

MeasureTime frame
fetal distress (monitor assessment, cord ph)24 h
cesarean section rate24h

Countries

Israel

Contacts

Primary ContactYael Sciaky-Tamir, MD
yaels@hadassah.org.il+972-2-5844111
Backup ContactDrorith Hochner-Celnikier, MD
Hochner@hadassah.org.il+972-2-8544410

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026